Viewing Study NCT05594927


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2025-12-26 @ 4:09 AM
Study NCT ID: NCT05594927
Status: RECRUITING
Last Update Posted: 2024-08-07
First Post: 2022-10-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
Sponsor: Beijing Shenogen Biomedical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module